Walgreens on Thursday announced a first-of-its-kind partnership with the Department of Veterans Affairs to improve care coordination and integrate immunization records for more than 8.5 million VA-enrolled patients.
Diplomat on Tuesday announced that Stephen Brown has been named chief information officer.
Pharma Compliance Group on Tuesday announced the launch of its proprietary prescription analysis software LongitudeRx.
Par Pharmaceutical on Tuesday announced that it has started shipping amlodipine and valsartan tablets in all four dosage strengths.
Salix Pharmaceuticals and Progenics Pharmaceuticals announced that the Food and Drug Administration approved Relistor (methylnaltrexone bromide) subcutaneous injection in 12-mg dosage strength to treat constipation in patients taking opioids for chronic, non-cancer pain.
Camber Pharmaceuticals, a generic drugs supplier, presented Target with its "Outstanding Partnership" award for 2014.
Wholesaler H.D. Smith last week promoted Dmitrey Kuznetsov to VP generic pharmaceuticals.
Johnson & Johnson on Tuesday announced a definitive agreement to acquire Alios BioPharma, a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.8 billion in cash.
Health experts argue that there are tactics that payers and purchasers can deploy to help improve patient access.
According to a report released Monday by Thomson Reuters BioWorld, currently there are 700 follow-on biologics therapies moving through pipelines with many already approved.